Search

Your search keyword '"Visani, L."' showing total 217 results

Search Constraints

Start Over You searched for: Author "Visani, L." Remove constraint Author: "Visani, L."
217 results on '"Visani, L."'

Search Results

1. GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial

5. Cardioprotection beyond the guidelines: the SAFE trial results

6. Cardiological Safety of 5-Fraction Whole Breast Irradiation

8. Clinical Outcomes and Dosimetric Predictive Factors in Patients Undergoing Reirradiation for Recurrent Meningiomas

9. GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial

11. PD-0576 Stereotactic reirradiation for locally recurrent prostate cancer after definitive radiotherapy

12. PO-1269 Cardiological monitoring and safety of 5-fraction whole breast irradiation: SAFE-FORWARD study

14. 259TiP Treatment of oligometastatic breast cancer (OMBC): A randomised phase III trial comparing stereotactic ablative radiotherapy (SABR) and systemic treatment with systemic treatment alone as first-line treatment - TAORMINA

15. PD-0652 Re-irradiation of recurrent intracranial meningiomas: an Italian multicenter retrospective study

16. PO-1354 Pattern of failure after stereotactic body radiotherapy to liver metastases: impact of local control

17. PO-1459 Stereotactic salvage radiotherapy for prostate red relapse, early analysis from a prospective trial

18. P106 De-escalation of radiation therapy after primary systemic therapy in non-metastatic breast cancer: patterns of recurrence from a real-world single-centre cohort of patients

19. Radiotherapy in patients receiving anthracyclines: phase 3 SAFE trial (NCT2236806) interim analysis

20. 231P Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer

22. OC-0932 Preoperative radiation therapy in early breast cancer: phase II ROCK trial (NCT03520894)

23. OC-0935 Radiotherapy in patients receiving anthracyclines: phase 3 SAFE trial (NCT2236806) interim analysis

25. PO-1469 CT-Guided Fiducial Placement for Robotic Stereotactic Body Radiotherapy: Efficacy and Safety

28. 242P Impact of metastases directed radiation therapy on CDK4/6 inhibitors treatment for metastatic breast cancer

29. OC-0071 Safety and efficacy of concomitant radiation and CDK4/6 inhibitors in breast cancer patients

30. PO-1096 Safety of concurrent TDM-1 and radiotherapy for patients with residual HER2-positive breast cancer

31. PO-1138 Preoperative radiation therapy in breast cancer: preliminary results from ROCK trial (NCT03520894)

35. PD-0067: An ex vivo assay to detect radiosensitization by PARP-inhibitors in soft tissue sarcomas

38. PO-0928: Safety and efficacy of concomitant RT and CDK4/6 inhibitors in metastatic breast cancer patients.

40. 1369P Biochemical outcomes from ARTO trial (NCT03449719) a phase II randomized trial testing association between abiraterone acetate and stereotactic body radiation therapy in castrate-resistant prostate cancer patients

41. 1029 Anthracycline and trastuzumab-induced subclinical cardiac damage and its prevention in the SAFE trial. Myocardial strain imaging and 3D echo interim analysis data

42. Résultats français d’une enquête internationale sur les « patient-reported outcomes » électroniques réalisée par le Young Radiation Oncology Group de l’European Organization for the Research and Treatment of Cancer

43. EP1.04-02 Predictors of Lung Toxicity in First Line Pembrolizumb for Advanced NSCLC: An Interim Analysis of PRELUTOX Study

45. PV-0256 European survey on electronic patientreported outcomes by the EORTC young Radiation Oncology Group

49. Abstract P3-12-07: Conservative breast reconstruction: Outcomes of 146 consecutive cases of prepectoral, subcutaneous implant-based breast reconstruction in a single-Institution series

50. Abstract P4-16-04: Oral ibandronate for osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: secondary 5-year survival outcomes analysis of the single-center phase 2 BONADIUV trial

Catalog

Books, media, physical & digital resources